Circulation. 2004;110:227-239
doi: 10.1161/01.CIR.0000133317.49796.0E
doi: 10.1161/01.CIR.0000133317.49796.0E
(Circulation. 2004;110:227-239.)
© 2004 American Heart Association, Inc.
NCEP Report |
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
Abstract
The Adult Treatment Panel III (ATP III) of the National Cholesterol Education Program issued an evidence-based set of guidelines on cholesterol management in 2001. Since the publication of ATP III, 5 major clinical trials of statin therapy with clinical end points have been published. These trials addressed issues that were not examined in previous clinical trials of cholesterol-lowering therapy. The present document reviews the results of these recent trials and assesses their implications for cholesterol management. Therapeutic lifestyle changes (TLC) remain an essential modality in clinical management. The trials confirm the benefit of cholesterol-lowering therapy in high-risk patients and support the ATP III treatment goal of low-density lipoprotein cholesterol (LDL-C) <100 mg/dL. They support the inclusion of patients with diabetes in the high-risk category and confirm the benefits of LDL-lowering therapy in these patients. They further confirm that older persons benefit from therapeutic lowering of LDL-C. The major recommendations for modifications to footnote the ATP III treatment algorithm are the following. In high-risk persons, the recommended LDL-C goal is <100 mg/dL, but when risk is very high, an LDL-C goal of <70 mg/dL is a therapeutic option, ie, a reasonable clinical strategy, on the basis of available clinical trial evidence. This therapeutic option extends also to patients at very high risk who have a baseline LDL-C <100 mg/dL. Moreover, when a high-risk patient has high triglycerides or low high-density lipoprotein cholesterol (HDL-C), consideration can be given to combining a fibrate or nicotinic acid with an LDL-lowering drug. For moderately high-risk persons (2+ risk factors and 10-year risk 10% to 20%), the recommended LDL-C goal is <130 mg/dL, but an LDL-C goal <100 mg/dL is a therapeutic option on the basis of recent trial evidence. The latter option extends also to moderately high-risk persons with a baseline LDL-C of 100 to 129 mg/dL. When LDL-lowering drug therapy is employed in high-risk or moderately high-risk persons, it is advised that intensity of therapy be sufficient to achieve at least a 30% to 40% reduction in LDL-C levels. Moreover, any person at high risk or moderately high risk who has lifestyle-related risk factors (eg, obesity, physical inactivity, elevated triglycerides, low HDL-C, or metabolic syndrome) is a candidate for TLC to modify these risk factors regardless of LDL-C level. Finally, for people in lower-risk categories, recent clinical trials do not modify the goals and cutpoints of therapy.
Key Words: cholesterol • trials • lipoproteins • coronary disease
This article has been cited by other articles:
 |
|
 |
|
  J. A. Ladapo, F. A. Jaffer, U. Hoffmann, C. C. Thomson, F. Bamberg, W. Dec, D. M. Cutler, M. C. Weinstein, and G. S. Gazelle Clinical Outcomes and Cost-Effectiveness of Coronary Computed Tomography Angiography in the Evaluation of Patients With Chest Pain J. Am. Coll. Cardiol., December 15, 2009; 54(25): 2409 - 2422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Gibson, Y. B. Pride, C. P. Hochberg, S. Sloan, M. S. Sabatine, C. P. Cannon, and for the TIMI Study Group Effect of Intensive Statin Therapy on Clinical Outcomes Among Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy. J. Am. Coll. Cardiol., December 8, 2009; 54(24): 2290 - 2295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Caselli, E. Canali, M. L. Foschi, D. Santini, E. Di Angelantonio, N. G. Pandian, and S. De Castro Long-term prognostic significance of three-dimensional echocardiographic parameters of the left ventricle and left atrium Eur J Echocardiogr, December 7, 2009; (2009) jep198v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cassar, D. R. Holmes Jr, C. S. Rihal, and B. J. Gersh Chronic Coronary Artery Disease: Diagnosis and Management Mayo Clin. Proc., December 1, 2009; 84(12): 1130 - 1146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zhang, Y. Liu, X. T. Lu, Y. L. Wu, C. Zhang, X. P. Ji, R. Wang, C. X. Liu, J. B. Feng, H. Jiang, et al. Traditional Chinese medication Tongxinluo dose-dependently enhances stability of vulnerable plaques: a comparison with a high-dose simvastatin therapy Am J Physiol Heart Circ Physiol, December 1, 2009; 297(6): H2004 - H2014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bass, A. L Hinderliter, and C. R Lee The Impact of Ezetimibe on Endothelial Function and Other Markers of Cardiovascular Risk Ann. Pharmacother., December 1, 2009; 43(12): 2021 - 2030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M Backes, P. A Howard, J. F Ruisinger, and P. M Moriarty Does Simvastatin Cause More Myotoxicity Compared with Other Statins? Ann. Pharmacother., December 1, 2009; 43(12): 2012 - 2020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
American College of Cardiology Foundation, American Heart Association Task Force on Practice, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interve, Society for Vascular Medicine, Society for Vascular Surgery, L. A. Fleisher, et al. 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery J. Am. Coll. Cardiol., November 24, 2009; 54(22): e13 - e118. [Full Text] [PDF]
|
|
|
|
 |
|
 2007 WRITING COMMITTEE MEMBERS, L. A. Fleisher, J. A. Beckman, K. A. Brown, H. Calkins, E. L. Chaikof, K. E. Fleischmann, W. K. Freeman, J. B. Froehlich, E. K. Kasper, et al. 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation, November 24, 2009; 120(21): e169 - e276. [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Chen, R. S. Punglia, K. M. Kuntz, P. M. Mauch, and A. K. Ng Cost Effectiveness and Screening Interval of Lipid Screening in Hodgkin's Lymphoma Survivors J. Clin. Oncol., November 10, 2009; 27(32): 5383 - 5389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sharma, M. T. Ansari, A. M. Abou-Setta, K. Soares-Weiser, T. C. Ooi, M. Sears, F. Yazdi, A. Tsertsvadze, and D. Moher Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia Ann Intern Med, November 3, 2009; 151(9): 622 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sethi Management of Hyperlipidemia in Patients With Abdominal Aortic Aneurysm Ann Intern Med, November 3, 2009; 151(9): 670 - 670. [Full Text] [PDF]
|
|
|
|
|
|
F. A. Lederle Management of Hyperlipidemia in Patients With Abdominal Aortic Aneurysm Ann Intern Med, November 3, 2009; 151(9): 670 - 670. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Z. Willey, Q. Xu, B. Boden-Albala, M. C. Paik, Y. P. Moon, R. L. Sacco, and M. S. V. Elkind Lipid Profile Components and Risk of Ischemic Stroke: The Northern Manhattan Study (NOMAS) Arch Neurol, November 1, 2009; 66(11): 1400 - 1406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Stirban, D. Tschoepe, and B. Stratmann Shifting the Disease Management Paradigm From Glucose: What are the pros? Diabetes Care, November 1, 2009; 32(suppl_2): S349 - S352. [Full Text] [PDF]
|
|
|
|
|
|
R. P. Morrissey, G. A. Diamond, and S. Kaul Statins in Acute Coronary Syndromes: Do the Guideline Recommendations Match the Evidence? J. Am. Coll. Cardiol., October 6, 2009; 54(15): 1425 - 1433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Helfand, D. I. Buckley, M. Freeman, R. Fu, K. Rogers, C. Fleming, and L. L. Humphrey Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force Ann Intern Med, October 6, 2009; 151(7): 496 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kumar and C. P. Cannon Acute Coronary Syndromes: Diagnosis and Management, Part I Mayo Clin. Proc., October 1, 2009; 84(10): 917 - 938. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
American College of Cardiology Foundation, American Heart Association, American College of Physicians Task Force on Compe, American Academy of Neurology, American Association of Cardiovascular and Pulmona, American College of Preventive Medicine, American Diabetes Association, American Society of Hypertension, Association of Black Cardiologists, National Lipid Association, et al. ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease. J. Am. Coll. Cardiol., September 29, 2009; 54(14): 1336 - 1363. [Full Text] [PDF]
|
|
|
|
|
|
WRITING COMMITTEE MEMBERS, C. N. Bairey Merz, M. J. Alberts, G. J. Balady, C. M. Ballantyne, K. Berra, H. R. Black, R. S. Blumenthal, M. H. Davidson, S. B. Fazio, et al. ACCF/AHA/ACP 2009 Competence and Training Statement: A Curriculum on Prevention of Cardiovascular Disease: A Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): Developed in Collaboration With the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association Circulation, September 29, 2009; 120(13): e100 - e126. [Full Text] [PDF]
|
|
|
|
 |
|
 R. O. Bonow Should Coronary Calcium Screening Be Used in Cardiovascular Prevention Strategies? N. Engl. J. Med., September 3, 2009; 361(10): 990 - 997. [Full Text] [PDF]
|
|
|
|
 |
|
 O. J. Liakopoulos, Y.-H. Choi, E. W. Kuhn, T. Wittwer, M. Borys, N. Madershahian, G. Wassmer, and T. Wahlers Statins for prevention of atrial fibrillation after cardiac surgery: A systematic literature review J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 678 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Zhang, A. Matsunaga, D. L. Rainwater, S.-i. Miura, K. Noda, H. Nishikawa, Y. Uehara, K. Shirai, M. Ogawa, and K. Saku Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY Study J. Lipid Res., September 1, 2009; 50(9): 1832 - 1841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Miller Dyslipidemia and cardiovascular risk: the importance of early prevention QJM, September 1, 2009; 102(9): 657 - 667. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tomaszewski, F. J. Charchar, T. Barnes, M. Gawron-Kiszka, A. Sedkowska, E. Podolecka, J. Kowalczyk, W. Rathbone, Z. Kalarus, W. Grzeszczak, et al. A Common Variant in Low-Density Lipoprotein Receptor-Related Protein 6 Gene (LRP6) Is Associated With LDL-Cholesterol Arterioscler Thromb Vasc Biol, September 1, 2009; 29(9): 1316 - 1321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ruggenenti, D. Cattaneo, G. Loriga, F. Ledda, N. Motterlini, G. Gherardi, S. Orisio, and G. Remuzzi Ameliorating Hypertension and Insulin Resistance in Subjects at Increased Cardiovascular Risk: Effects of Acetyl-L-Carnitine Therapy Hypertension, September 1, 2009; 54(3): 567 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sharma, M. T. Ansari, A. M. Abou-Setta, K. Soares-Weiser, T. C. Ooi, M. Sears, F. Yazdi, A. Tsertsvadze, and D. Moher Systematic Review: Comparative Effectiveness and Harms of Combinations of Lipid-Modifying Agents and High-Dose Statin Monotherapy Ann Intern Med, August 31, 2009; (2009) 0000605-200911030-00144v1. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. S. Martin, A. N. Qasim, N. N. Mehta, M. Wolfe, K. Terembula, S. Schwartz, N. Iqbal, M. Schutta, R. Bagheri, and M. P. Reilly Apolipoprotein B but not LDL Cholesterol Is Associated With Coronary Artery Calcification in Type 2 Diabetic Whites Diabetes, August 1, 2009; 58(8): 1887 - 1892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F F Faletra, C Klersy, I D'Angeli, M Penco, V Procaccini, E Pasotti, A Marcolongo, G B Pedrazzini, S De Castro, M Scappaticci, et al. Relation between coronary atherosclerotic plaques and traditional risk factors in people with no history of cardiovascular disease undergoing multi-detector computed coronary angiography Heart, August 1, 2009; 95(15): 1265 - 1272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. P. Carr, K. L. S. Krogstrand, V. L. Schlegel, and M. L. Fernandez Stearate-Enriched Plant Sterol Esters Lower Serum LDL Cholesterol Concentration in Normo- and Hypercholesterolemic Adults J. Nutr., August 1, 2009; 139(8): 1445 - 1450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Etzion, A. Hackett, B. M. Proctor, J. Ren, B. Nolan, T. Ellenberger, and A. J. Muslin An Unbiased Chemical Biology Screen Identifies Agents That Modulate Uptake of Oxidized LDL by Macrophages Circ. Res., July 17, 2009; 105(2): 148 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Jackevicius, J. L. Cox, D. Carreon, J. V. Tu, S. Rinfret, D. So, H. Johansen, D. Kalavrouziotis, V. Demers, K. Humphries, et al. Long-term trends in use of and expenditures for cardiovascular medications in Canada Can. Med. Assoc. J., July 7, 2009; 181(1-2): E19 - E28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Gotto Jr Improving Lipid Goal Attainment: Is It Enough? Circulation, July 7, 2009; 120(1): 3 - 5. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Brunelli, A. Charloux, C. T. Bolliger, G. Rocco, J-P. Sculier, G. Varela, M. Licker, M. K. Ferguson, C. Faivre-Finn, R. M. Huber, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Eur. Respir. J., July 1, 2009; 34(1): 17 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Shea, R. S Weinstock, J. A Teresi, W. Palmas, J. Starren, J. J Cimino, A. M Lai, L. Field, P. C Morin, R. Goland, et al. A Randomized Trial Comparing Telemedicine Case Management with Usual Care in Older, Ethnically Diverse, Medically Underserved Patients with Diabetes Mellitus: 5 Year Results of the IDEATel Study JAMIA, July 1, 2009; 16(4): 446 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-K. Hong, D.-W. Park, C.-W. Lee, S.-W. Lee, Y.-H. Kim, D.-H. Kang, J.-K. Song, J.-J. Kim, S.-W. Park, and S.-J. Park Effects of Statin Treatments on Coronary Plaques Assessed by Volumetric Virtual Histology Intravascular Ultrasound Analysis J. Am. Coll. Cardiol. Intv., July 1, 2009; 2(7): 679 - 688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Meaney, G. Ceballos, J. Asbun, G. Solache, E. Mendoza, A. Vela, and E. Meaney The Vytorin on Carotid Intima-Media Thickness and Overall Arterial Rigidity (VYCTOR) Study J. Clin. Pharmacol., July 1, 2009; 49(7): 838 - 847. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J M Wilson Diagnosis and treatment of acquired coronary artery disease in adults Postgrad. Med. J., July 1, 2009; 85(1005): 364 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J J Brugts, T Yetgin, S E Hoeks, A M Gotto, J Shepherd, R G J Westendorp, A J M de Craen, R H Knopp, H Nakamura, P Ridker, et al. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials BMJ, June 30, 2009; 338(jun30_1): b2376 - b2376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. A. Jenkins, J. M. W. Wong, C. W. C. Kendall, A. Esfahani, V. W. Y. Ng, T. C. K. Leong, D. A. Faulkner, E. Vidgen, K. A. Greaves, G. Paul, et al. The Effect of a Plant-Based Low-Carbohydrate ("Eco-Atkins") Diet on Body Weight and Blood Lipid Concentrations in Hyperlipidemic Subjects Arch Intern Med, June 8, 2009; 169(11): 1046 - 1054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Hennekens, W. R. Schneider, E. J. Barice, and P. R. Hebert Modest Dietary Reductions in Blood Cholesterol Have Important Public Health Benefits Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2009; 14(2): 85 - 88. [Abstract] [PDF]
|
|
|
|
 |
|
 C. L. Von Zee, M. P. Richards, P. Bu, J. I. Perlman, and E. B. Stubbs Jr Increased RhoA and RhoB Protein Accumulation in Cultured Human Trabecular Meshwork Cells by Lovastatin Invest. Ophthalmol. Vis. Sci., June 1, 2009; 50(6): 2816 - 2823. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Goumas LDL-Cholesterol is the King Angiology, June 1, 2009; 60(3): 387 - 388. [PDF]
|
|
|
|
 |
|
 A. Brautbar, C. M. Ballantyne, K. Lawson, V. Nambi, L. Chambless, A. R. Folsom, J. T. Willerson, and E. Boerwinkle Impact of Adding a Single Allele in the 9p21 Locus to Traditional Risk Factors on Reclassification of Coronary Heart Disease Risk and Implications for Lipid-Modifying Therapy in the Atherosclerosis Risk in Communities Study Circ Cardiovasc Genet, June 1, 2009; 2(3): 279 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Zurru, C. Alonzo, L. Brescacin, M. Romano, L. A. Camera, G. Waisman, E. Cristiano, and B. Ovbiagele Recent Respiratory Infection Predicts Atherothrombotic Stroke: Case-Control Study in a Buenos Aires Healthcare System Stroke, June 1, 2009; 40(6): 1986 - 1990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Williams, H. Patrick, C. P. Niemiec, L. K. Williams, G. Divine, J. E. Lafata, M. Heisler, K. Tunceli, and M. Pladevall Reducing the Health Risks of Diabetes: How Self-determination Theory May Help Improve Medication Adherence and Quality of Life The Diabetes Educator, May 1, 2009; 35(3): 484 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. S. Ramanath, J. K. Oh, T. M. Sundt III, and K. A. Eagle Acute Aortic Syndromes and Thoracic Aortic Aneurysm Mayo Clin. Proc., May 1, 2009; 84(5): 465 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. R Doucette, M. J Witry, K. B Farris, and R. P McDonough Community Pharmacist-Provided Extended Diabetes Care Ann. Pharmacother., May 1, 2009; 43(5): 882 - 889. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. O'Neill, J. M. Pego-Reigosa, A. D. Hingorani, R. Bessant, D. A. Isenberg, and A. Rahman Use of a strategy based on calculated risk scores in managing cardiovascular risk factors in a large British cohort of patients with systemic lupus erythematosus Rheumatology, May 1, 2009; 48(5): 573 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Bertoni, D. E. Bonds, H. Chen, P. Hogan, L. Crago, E. Rosenberger, A. H. Barham, C. R. Clinch, and D. C. Goff Jr Impact of a Multifaceted Intervention on Cholesterol Management in Primary Care Practices: Guideline Adherence for Heart Health Randomized Trial Arch Intern Med, April 13, 2009; 169(7): 678 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Nuzum and T. Merz Macrovascular Complications of Diabetes Mellitus Journal of Pharmacy Practice, April 1, 2009; 22(2): 135 - 148. [Abstract] [PDF]
|
|
|
|
|
|
P. Rerkpattanapipat, R. B. D'Agostino Jr, K. M. Link, E. Shahar, J. A. Lima, D. A. Bluemke, S. Sinha, D. M. Herrington, and W. G. Hundley Location of Arterial Stiffening Differs in Those With Impaired Fasting Glucose Versus Diabetes: Implications for Left Ventricular Hypertrophy From the Multi-Ethnic Study of Atherosclerosis Diabetes, April 1, 2009; 58(4): 946 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Stein Low-Density Lipoprotein Cholesterol Reduction and Prevention of Cardiovascular Disease Mayo Clin. Proc., April 1, 2009; 84(4): 307 - 309. [Full Text] [PDF]
|
|
|
|
|
|
D. G. Karalis Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease Mayo Clin. Proc., April 1, 2009; 84(4): 345 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Roberts, P. B. Gorelick, X. Ye, C. Harley, and G. A. Goldberg Additional Stroke-Related and Non-Stroke-Related Cardiovascular Costs and Hospitalizations in Managed-Care Patients After Ischemic Stroke Stroke, April 1, 2009; 40(4): 1425 - 1432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U Laufs, F Custodis, and M Bohm Who does not need a statin: too late in end-stage renal disease or heart failure? Postgrad. Med. J., April 1, 2009; 85(1002): 187 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Chhatriwalla, S. J. Nicholls, T. H. Wang, K. Wolski, I. Sipahi, T. Crowe, P. Schoenhagen, S. Kapadia, E. M. Tuzcu, and S. E. Nissen Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis. J. Am. Coll. Cardiol., March 31, 2009; 53(13): 1110 - 1115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Silverberg, W. Leyden, L. Hurley, A. S. Go, C. P. Quesenberry Jr., D. Klein, and M. A. Horberg Response to Newly Prescribed Lipid-Lowering Therapy in Patients With and Without HIV Infection Ann Intern Med, March 3, 2009; 150(5): 301 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Kostapanos, H. J. Milionis, T. D. Filippatos, L. G. Christogiannis, E. T. Bairaktari, A. D. Tselepis, and M. S. Elisaf Dose-dependent Effect of Rosuvastatin Treatment on HDL-subfraction Phenotype in Patients With Primary Hyperlipidemia Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2009; 14(1): 5 - 13. [Abstract] [PDF]
|
|
|
|
|
|
P. A. VanderLaan, C. A. Reardon, R. A. Thisted, and G. S. Getz VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice J. Lipid Res., March 1, 2009; 50(3): 376 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Talati, W. L. Baker, M. S. Pabilonia, C. M. White, and C. I. Coleman The Effects of Barley-Derived Soluble Fiber on Serum Lipids Ann. Fam. Med, March 1, 2009; 7(2): 157 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. Alexander, M. A. Blazing, R. S. Rosenson, E. Hazard, W. S. Aronow, S. C. Smith Jr, and E. M. Ohman Management of Hyperlipidemia in Older Adults Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2009; 14(1): 49 - 58. [Abstract] [PDF]
|
|
|
|
 |
|
 Heart Protection Study Collaborative Group Statin Cost-Effectiveness in the United States for People at Different Vascular Risk Levels Circ Cardiovasc Qual Outcomes, March 1, 2009; 2(2): 65 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Charlton-Menys, D. J. Betteridge, H. Colhoun, J. Fuller, M. France, G. A. Hitman, S. J. Livingstone, H. A. W. Neil, C. B. Newman, M. Szarek, et al. Targets of Statin Therapy: LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B in Type 2 Diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS) Clin. Chem., March 1, 2009; 55(3): 473 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Lester, M. F. Eleid, B. K. Khandheria, and R. T. Hurst Carotid Intima-Media Thickness and Coronary Artery Calcium Score as Indications of Subclinical Atherosclerosis Mayo Clin. Proc., March 1, 2009; 84(3): 229 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M Trompeter and D. E Havrda Impact of Obtaining Medications from Pharmaceutical Company Assistance Programs on Therapeutic Goals Ann. Pharmacother., March 1, 2009; 43(3): 469 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Pletcher, L. Lazar, K. Bibbins-Domingo, A. Moran, N. Rodondi, P. Coxson, J. Lightwood, L. Williams, and L. Goldman Comparing Impact and Cost-Effectiveness of Primary Prevention Strategies for Lipid-Lowering Ann Intern Med, February 17, 2009; 150(4): 243 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Dunn, B. Bleske, M. Dorsch, T. Macaulay, B. Van Tassell, and O. Vardeny Nutrition and Heart Failure: Impact of Drug Therapies and Management Strategies Nutr Clin Pract, February 1, 2009; 24(1): 60 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Whayne Jr Response to Letter of Mascitelli L, Ravnskov U, Pezzetta F, and Goldstein M Angiology, February 1, 2009; 60(1): 129 - 130. [PDF]
|
|
|
|
 |
|
 M. McDonald, R. P. Hertz, A. N. Unger, and M. B. Lustik Prevalence, Awareness, and Management of Hypertension, Dyslipidemia, and Diabetes Among United States Adults Aged 65 and Older J Gerontol A Biol Sci Med Sci, February 1, 2009; 64A(2): 256 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Robinson, S. Wang, B. J. Smith, and T. A. Jacobson Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. J. Am. Coll. Cardiol., January 27, 2009; 53(4): 316 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. SHISHEHBOR and S. L. HAZEN JUPITER to Earth: A statin helps people with normal LDL-C and high hs-CRP, but what does it mean? Cleveland Clinic Journal of Medicine, January 1, 2009; 76(1): 37 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Nathan, J. B. Buse, M. B. Davidson, E. Ferrannini, R. R. Holman, R. Sherwin, and B. Zinman Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Clin. Diabetes, January 1, 2009; 27(1): 4 - 16. [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Nathan, J. B. Buse, M. B. Davidson, E. Ferrannini, R. R. Holman, R. Sherwin, and B. Zinman Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Spectr, January 1, 2009; 22(1): 6 - 17. [Full Text] [PDF]
|
|
|
|
|
|
E. S. Spatz, M. E. Canavan, and M. M. Desai From Here to JUPITER: Identifying New Patients for Statin Therapy Using Data From the 1999-2004 National Health and Nutrition Examination Survey Circ Cardiovasc Qual Outcomes, January 1, 2009; 2(1): 41 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Johnson, D. A. Dowe, and J. A. Brink Traditional Clinical Risk Assessment Tools Do Not Accurately Predict Coronary Atherosclerotic Plaque Burden: A CT Angiography Study Am. J. Roentgenol., January 1, 2009; 192(1): 235 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Nathan, J. B. Buse, M. B. Davidson, E. Ferrannini, R. R. Holman, R. Sherwin, and B. Zinman Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care, January 1, 2009; 32(1): 193 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
American Diabetes Association Standards of Medical Care in Diabetes--2009 Diabetes Care, January 1, 2009; 32(Supplement_1): S13 - S61. [Full Text] [PDF]
|
|
|
|
|
|
E. A. Stein Additional Lipid Lowering Trials Using Surrogate Measurements of Atherosclerosis by Carotid Intima-Media Thickness: More Clarity or Confusion? J. Am. Coll. Cardiol., December 16, 2008; 52(25): 2206 - 2209. [Full Text] [PDF]
|
|
|
|
 |
|
 S. I. Rennard Lessons from Multidisciplinary Cross-Fertilization: Chronic Obstructive Pulmonary Disease, Lung Cancer, and Heart Disease Proceedings of the ATS, December 1, 2008; 5(8): 865 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-A. Cornier, D. Dabelea, T. L. Hernandez, R. C. Lindstrom, A. J. Steig, N. R. Stob, R. E. Van Pelt, H. Wang, and R. H. Eckel The Metabolic Syndrome Endocr. Rev., December 1, 2008; 29(7): 777 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Voora, S. H. Shah, C. R. Reed, J. Zhai, D. R. Crosslin, C. Messer, B. A. Salisbury, and G. S. Ginsburg Pharmacogenetic Predictors of Statin-Mediated Low-Density Lipoprotein Cholesterol Reduction and Dose Response Circ Cardiovasc Genet, December 1, 2008; 1(2): 100 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Krasuski Primary Prevention and Statins: Is It Just About Going to Class? Mayo Clin. Proc., December 1, 2008; 83(12): 1313 - 1315. [Full Text] [PDF]
|
|
|
|
|
|
T. A. Jacobson, D. A. Wertz, T. Hoy, A. Kuznik, D. Grochulski, and M. Cziraky Comparison of Cardiovascular Event Rates in Patients Without Cardiovascular Disease in Whom Atorvastatin or Simvastatin Was Newly Initiated Mayo Clin. Proc., December 1, 2008; 83(12): 1316 - 1325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sillesen, P. Amarenco, M. G. Hennerici, A. Callahan, L. B. Goldstein, J. Zivin, M. Messig, K. M. Welch, and on Behalf of the SPARCL Investigators Atorvastatin Reduces the Risk of Cardiovascular Events in Patients With Carotid Atherosclerosis: A Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial Stroke, December 1, 2008; 39(12): 3297 - 3302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M Ridker, N. P. Paynter, N. Rifai, J. M. Gaziano, and N. R. Cook C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men Circulation, November 25, 2008; 118(22): 2243 - 2251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M Ridker, E. Danielson, F. A.H. Fonseca, J. Genest, A. M. Gotto Jr., J. J.P. Kastelein, W. Koenig, P. Libby, A. J. Lorenzatti, J. G. MacFadyen, et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein N. Engl. J. Med., November 20, 2008; 359(21): 2195 - 2207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Joras and P. Poredos The association of acute exercise-induced ischaemia with systemic vasodilator function in patients with peripheral arterial disease Vascular Medicine, November 1, 2008; 13(4): 255 - 262. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Y. Tomoum, M. M. Awadallah, D. A. Fouad, and A. H. Ali Lipid Profile, Apolipoproteins A and B in Children With Epilepsy J Child Neurol, November 1, 2008; 23(11): 1275 - 1281. [Abstract] [PDF]
|
|
|
|
 |
|
 G Ferns, V Keti, and B Griffin Investigation and management of hypertriglyceridaemia J. Clin. Pathol., November 1, 2008; 61(11): 1174 - 1183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D J Hausenloy and D M Yellon Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels Postgrad. Med. J., November 1, 2008; 84(997): 590 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kulik, M. A. Brookhart, R. Levin, M. Ruel, D. H. Solomon, and N. K. Choudhry Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery Circulation, October 28, 2008; 118(18): 1785 - 1792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Roe, F.-S. Ou, K. P. Alexander, L. K. Newby, J. M. Foody, W. B. Gibler, W. E. Boden, E. M. Ohman, S. C. Smith Jr, and E. D. Peterson Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromes Eur. Heart J., October 2, 2008; 29(20): 2480 - 2488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sood, W. L Baker, and C. I Coleman Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis Am. J. Clinical Nutrition, October 1, 2008; 88(4): 1167 - 1175. [Abstract] [Full Text] [PDF]
|
|